Fulcrum Therapeutics’ $125 Million Public Offering of Common Stock

Martina Bellini
Tagged:

Goodwin Procter advised Fulcrum Therapeutics on the deal.Fulcrum Therapeutics, Inc. (Nasdaq: FULC) announced its underwritten public offering of 9,615,384 shares of its common stock at a…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now